Is the Newest Member of the Nasdaq-100 — a 764% Gainer Since Its IPO — a Buy Going Into 2025? todayheadline

Published on December 25, 2024

of retail investors and notable institutional funds. While this all appears like a recipe that makes Palantir a no-brainer investment, the

Continue reading on website
Other news

JUJA polls on 30 Dec

December 25, 2024
he said during a discussion.Zia Shishu-Kishor Mela, a pro-BNP platform, organised the programme at the Jatiya Press Club, marking the 29th

Market Momentum Report: Xilio Therapeutics Inc (XLO)’s Positive Close at 1.15

December 25, 2024
thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets